Gabriela Araujo Munhoz
Gabriela Araujo Munhoz has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Adriana Maria Kakehasi
Departamento do Aparelho Locomotor, Faculdade de Medicina, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte 30130-100, MG, Brazil
2 shared publications - Ana Paula Monteiro Gomides
Centro Universitário de Brasília, Brasília, Brazil
2 shared publications - Claudia Diniz Lopes Marques
Universidade Federal de Pernambuco – UFPE, Recife, Brasil
2 shared publications - Débora Cerqueira Calderaro
Federal University of Minas Gerais
2 shared publications - Edgard Torres dos Reis-Neto
Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), São Paulo 04023-062, SP, Brazil
2 shared publications - Eduardo Ferreira Borba
Universidade de São Paulo
2 shared publications
Latest Publications
- Open Access
- 1 March 2024
- Published by Universidade de São Paulo. Agência de Bibliotecas e Coleções Digitais
Avaliação de envolvimento de novos órgãos e acúmulo de dano em coorte de pacientes recém diagnosticados com lúpus eritematoso sistêmico com e sem nefrite
Introdução: O acometimento renal se manifesta geralmente no início do lúpus eritematoso sistêmico (LES) e sua incidência diminui significativamente após os primeiros 5 anos do diagnóstico. Há poucos dados...
- 1 March 2024
- Published by Universidade de São Paulo. Agência de Bibliotecas e Coleções Digitais
Open AccessAvaliação de envolvimento de novos órgãos e acúmulo de dano em coorte de pacientes recém diagnosticados com lúpus eritematoso sistêmico com e sem nefrite
Introdução: O acometimento renal se manifesta geralmente no início do lúpus eritematoso sistêmico (LES) e sua incidência diminui significativamente após os primeiros 5 anos do diagnóstico. Há poucos dados...
- 23 January 2023
- Published by Wolters Kluwer Health in JCR: Journal of Clinical Rheumatology
- Vol. 29 (4) , 190-195
Short-term Accrual 2019 European League Against Rheumatism/American College of Rheumatology Domains and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage in Lupus Patients With and Without Nephritis at Disease Onset
Objective: To determine in a historical inception cohort the impact of lupus nephritis at disease onset in short-term accrual 2019 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) domains. The possible association with treatment and damage was also investigated. Methods: One hundred thirty-three consecutive adult systemic lupus erythematosus patients according to the 2019 EULAR/ACR criteria were divided according to the presence (RENAL-lupus) or absence of renal involvement (NONRENAL-lupus) at disease onset. The 2019 EULAR/ACR score and Systemic Lupus International Collaborating Clinics/ACR (SDI) were longitudinally evaluated over 3 years. Results: RENAL-lupus (n = 49 [36.8%]) and NONRENAL-lupus (n = 84 [63.2%]) were similar regarding age (p = 0.704), female sex (p = 0.313), and black race (p = 0.506). At study entry, RENAL-lupus had higher 2019 EULAR/ACR total domains (30 [12–42] vs. 22 [10–36], p < 0.001) and used more often glucocorticoid (p < 0.001), mycophenolate mofetil (p = 0.007), and cyclophosphamide (p = 0.001). After 3 years, a stable number of domain scores was observed for the RENAL-lupus (30 [12–42] vs. 30 [12–42], p = 0.125), whereas an increase was observed for the NONRENAL-lupus (22 [10–36] vs. 23 [10–40], p < 0.001) compared with baseline. Accordingly, RENAL-lupus patients had a lower frequency of additional domains (3/49 [6.1%] vs. 37/84 [44.0%], p < 0.0001). New kidney involvement occurred in 15 (44.1%) of 34 patients of the NONRENAL-lupus. Both groups evolved with a comparable increase in frequency of patients with damage (SDI ≥1) at the end of the study (23/49 [46.9%] vs. 34/89 [40.54%], p = 0.585) with a similar median of SDI (1 [0–4] vs. 0 [0–2], p = 0.132). Conclusions: The distinct pattern of accrual 2019 EULAR/ACR domains in patients with and without nephritis at disease onset suggests that close surveillance for additional organ involvement, including kidney, is mandatory in NONRENAL lupus in the first 3 years of disease. The unexpected comparable early damage in both groups despite milder disease and less intense immunosuppression in NONRENAL lupus reinforces the need for new and tailored therapies for these patients.
- 23 January 2023
- Published by Wolters Kluwer Health in JCR: Journal of Clinical Rheumatology
- Vol. 29 (4) , 190-195
Short-term Accrual 2019 European League Against Rheumatism/American College of Rheumatology Domains and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage in Lupus Patients With and Without Nephritis at Disease Onset
Objective: To determine in a historical inception cohort the impact of lupus nephritis at disease onset in short-term accrual 2019 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) domains. The possible association with treatment and damage was also investigated. Methods: One hundred thirty-three consecutive adult systemic lupus erythematosus patients according to the 2019 EULAR/ACR criteria were divided according to the presence (RENAL-lupus) or absence of renal involvement (NONRENAL-lupus) at disease onset. The 2019 EULAR/ACR score and Systemic Lupus International Collaborating Clinics/ACR (SDI) were longitudinally evaluated over 3 years. Results: RENAL-lupus (n = 49 [36.8%]) and NONRENAL-lupus (n = 84 [63.2%]) were similar regarding age (p = 0.704), female sex (p = 0.313), and black race (p = 0.506). At study entry, RENAL-lupus had higher 2019 EULAR/ACR total domains (30 [12–42] vs. 22 [10–36], p < 0.001) and used more often glucocorticoid (p < 0.001), mycophenolate mofetil (p = 0.007), and cyclophosphamide (p = 0.001). After 3 years, a stable number of domain scores was observed for the RENAL-lupus (30 [12–42] vs. 30 [12–42], p = 0.125), whereas an increase was observed for the NONRENAL-lupus (22 [10–36] vs. 23 [10–40], p < 0.001) compared with baseline. Accordingly, RENAL-lupus patients had a lower frequency of additional domains (3/49 [6.1%] vs. 37/84 [44.0%], p < 0.0001). New kidney involvement occurred in 15 (44.1%) of 34 patients of the NONRENAL-lupus. Both groups evolved with a comparable increase in frequency of patients with damage (SDI ≥1) at the end of the study (23/49 [46.9%] vs. 34/89 [40.54%], p = 0.585) with a similar median of SDI (1 [0–4] vs. 0 [0–2], p = 0.132). Conclusions: The distinct pattern of accrual 2019 EULAR/ACR domains in patients with and without nephritis at disease onset suggests that close surveillance for additional organ involvement, including kidney, is mandatory in NONRENAL lupus in the first 3 years of disease. The unexpected comparable early damage in both groups despite milder disease and less intense immunosuppression in NONRENAL lupus reinforces the need for new and tailored therapies for these patients.
- Open Access
- 10 May 2021
- Published by Clinical and Experimental Rheumatology in Clinical and Experimental Rheumatology
- Vol. 40 (7) , 1258-1266
Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort
Full Papers; Authors: M.M. Pinheiro, G.S. Pileggi, A.M. Kakehasi, A.P.M. Gomides Reis, E.T. Reis-Neto, M.M. Abreu, C.P. Albuquerque, N.C. Araújo, A.B. Bacchiega, D.V. Bianchi, B. Bica, E. Bonfa, E.F. Borba, D.C. Egypto Brito, D.C. Calderaro, Â.L. Pinto Duarte, R.C. Espírito Santo, P.R. Fernandes, M.P. Guimarães, K.W. Poti Gomes, G.G. Faustino Ilana, E.M. Klumb, C.D. Marques, A.K. Guedes De Melo, O.A. Monticielo, L.M. Mota, G.A. Munhoz, E.S. Paiva, H.L.A. Pereira, J.R. Provenza, S.L.E. Ribeiro, L.F. Rocha Jr, E.I. Sato, T. Skare, V.A. De Souza, V. Valim, M.V. Lacerda, R.M. Xavier, G.A. Ferreira
- 10 May 2021
- Published by Clinical and Experimental Rheumatology in Clinical and Experimental Rheumatology
- Vol. 40 (7) , 1258-1266
Open AccessIncidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort
Full Papers; Authors: M.M. Pinheiro, G.S. Pileggi, A.M. Kakehasi, A.P.M. Gomides Reis, E.T. Reis-Neto, M.M. Abreu, C.P. Albuquerque, N.C. Araújo, A.B. Bacchiega, D.V. Bianchi, B. Bica, E. Bonfa, E.F. Borba, D.C. Egypto Brito, D.C. Calderaro, Â.L. Pinto Duarte, R.C. Espírito Santo, P.R. Fernandes, M.P. Guimarães, K.W. Poti Gomes, G.G. Faustino Ilana, E.M. Klumb, C.D. Marques, A.K. Guedes De Melo, O.A. Monticielo, L.M. Mota, G.A. Munhoz, E.S. Paiva, H.L.A. Pereira, J.R. Provenza, S.L.E. Ribeiro, L.F. Rocha Jr, E.I. Sato, T. Skare, V.A. De Souza, V. Valim, M.V. Lacerda, R.M. Xavier, G.A. Ferreira
- Open Access
- 9 April 2021
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 10 (4) , e24617
Effects of Participating in a Research Project During the COVID-19 Pandemic on Medical Students’ Educational Routines and Mental Health: Protocol for a Web-Based Survey Study
Background: The COVID-19 pandemic has resulted in social isolation, which has a potential negative impact on the educational routines (eg, the suspension of face-to-face appointments) and mental health of medical students. The Mario Pinotti II (MPII) study is a 24-week observational study that conducted scheduled telephone calls every 2 weeks to verify the occurrence of COVID-19 in patients with rheumatic diseases on chronic hydroxychloroquine therapy (from March 29, 2020, to September 30, 2020). The effects of voluntarily participating in a research project (ie, one that involves interactions via telephone contact with patients, professors, rheumatologists, and colleagues) on the daily lives and mental health of medical students requires evaluation. Objective: As medical students are professionals in training and have a high level of responsibility in terms of handling the emotional and physical aspects of several diseases, this study aims to evaluate the impacts of the COVID-19 pandemic and participation in the MPII study on the educational routines and mental health of medical students. Methods: A web-based survey was carried out to perform a cross-sectional comparative assessment of medical students who participated in the MPII study and their colleagues who were not involved in the MPII study. Participants from both groups were matched based on sex, age, and medical school. The web questionnaire was developed by a panel composed of graduate medical students, rheumatologists, medical school professors, and a psychology professor. The questionnaire included details on demographic and life habits data and evaluated participants' impressions of the MPII study and the impact of the COVID-19 pandemic on their educational routines and medical training. In addition, depression, anxiety, and stress were evaluated using the Brazilian version of the Depression, Anxiety, and Stress Scale (DASS)-21, and currently, the DASS-21 scores are grouped as those that indicate a low, moderate, or high risk of mental distress. This project was approved by the Federal University of São Paulo Ethics Committee (CAAE: 34034620.0.0000.5505). Results: Data were collected from both medical student groups from July 20 to August 31, 2020. Data extraction was completed in September 2020. The data analysis is ongoing. We expect the results to be published in the first semester of 2021. Conclusions: This study will provide insight into the effects of participating in a research project on depression, anxiety, and stress, which will be determined by applying the DASS-21 to a large sample of Brazilian undergraduate medical students. We will also evaluate the impact of the COVID-19 pandemic on medical students’ educational routines and medical training.
- 9 April 2021
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 10 (4) , e24617
Open AccessEffects of Participating in a Research Project During the COVID-19 Pandemic on Medical Students’ Educational Routines and Mental Health: Protocol for a Web-Based Survey Study
Background: The COVID-19 pandemic has resulted in social isolation, which has a potential negative impact on the educational routines (eg, the suspension of face-to-face appointments) and mental health of medical students. The Mario Pinotti II (MPII) study is a 24-week observational study that conducted scheduled telephone calls every 2 weeks to verify the occurrence of COVID-19 in patients with rheumatic diseases on chronic hydroxychloroquine therapy (from March 29, 2020, to September 30, 2020). The effects of voluntarily participating in a research project (ie, one that involves interactions via telephone contact with patients, professors, rheumatologists, and colleagues) on the daily lives and mental health of medical students requires evaluation. Objective: As medical students are professionals in training and have a high level of responsibility in terms of handling the emotional and physical aspects of several diseases, this study aims to evaluate the impacts of the COVID-19 pandemic and participation in the MPII study on the educational routines and mental health of medical students. Methods: A web-based survey was carried out to perform a cross-sectional comparative assessment of medical students who participated in the MPII study and their colleagues who were not involved in the MPII study. Participants from both groups were matched based on sex, age, and medical school. The web questionnaire was developed by a panel composed of graduate medical students, rheumatologists, medical school professors, and a psychology professor. The questionnaire included details on demographic and life habits data and evaluated participants' impressions of the MPII study and the impact of the COVID-19 pandemic on their educational routines and medical training. In addition, depression, anxiety, and stress were evaluated using the Brazilian version of the Depression, Anxiety, and Stress Scale (DASS)-21, and currently, the DASS-21 scores are grouped as those that indicate a low, moderate, or high risk of mental distress. This project was approved by the Federal University of São Paulo Ethics Committee (CAAE: 34034620.0.0000.5505). Results: Data were collected from both medical student groups from July 20 to August 31, 2020. Data extraction was completed in September 2020. The data analysis is ongoing. We expect the results to be published in the first semester of 2021. Conclusions: This study will provide insight into the effects of participating in a research project on depression, anxiety, and stress, which will be determined by applying the DASS-21 to a large sample of Brazilian undergraduate medical students. We will also evaluate the impact of the COVID-19 pandemic on medical students’ educational routines and medical training.